Kyowa Kirin Co Ltd
TSE:4151
Intrinsic Value
Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. [ Read More ]
The intrinsic value of one Kyowa Kirin Co Ltd stock under the Base Case scenario is 3 593.25 JPY. Compared to the current market price of 2 653 JPY, Kyowa Kirin Co Ltd is Undervalued by 26%.
Valuation Backtest
Kyowa Kirin Co Ltd
Run backtest to discover the historical profit from buying and selling Kyowa Kirin Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Kyowa Kirin Co Ltd
Current Assets | 611.1B |
Cash & Short-Term Investments | 405B |
Receivables | 119.1B |
Other Current Assets | 87B |
Non-Current Assets | 414.8B |
Long-Term Investments | 45.7B |
PP&E | 94.5B |
Intangibles | 203.4B |
Other Non-Current Assets | 71.2B |
Current Liabilities | 133.2B |
Accounts Payable | 12.2B |
Other Current Liabilities | 121.1B |
Non-Current Liabilities | 56.3B |
Long-Term Debt | 16.1B |
Other Non-Current Liabilities | 40.2B |
Earnings Waterfall
Kyowa Kirin Co Ltd
Revenue
|
442.2B
JPY
|
Cost of Revenue
|
-111.2B
JPY
|
Gross Profit
|
331B
JPY
|
Operating Expenses
|
-237.2B
JPY
|
Operating Income
|
93.8B
JPY
|
Other Expenses
|
-12.7B
JPY
|
Net Income
|
81.2B
JPY
|
Free Cash Flow Analysis
Kyowa Kirin Co Ltd
Profitability Score
Profitability Due Diligence
Kyowa Kirin Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Kyowa Kirin Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Kyowa Kirin Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Kyowa Kirin Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Kyowa Kirin Co Ltd
According to Wall Street analysts, the average 1-year price target for Kyowa Kirin Co Ltd is 3 121.2 JPY with a low forecast of 2 727 JPY and a high forecast of 3 990 JPY.
Shareholder Return
Price
Kyowa Kirin Co Ltd
Average Annual Return | 11.04% |
Standard Deviation of Annual Returns | 11.71% |
Max Drawdown | -45% |
Market Capitalization | 1.4T JPY |
Shares Outstanding | 537 646 600 |
Percentage of Shares Shorted |
N/A
|
News
Last Important Events
Kyowa Kirin Co Ltd
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Kyowa Kirin Co Ltd
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 5,752 full-time employees. The firm operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.
Contact
IPO
Employees
Officers
The intrinsic value of one Kyowa Kirin Co Ltd stock under the Base Case scenario is 3 593.25 JPY.
Compared to the current market price of 2 653 JPY, Kyowa Kirin Co Ltd is Undervalued by 26%.